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ABSTRACT
Background: Results of studies of the association between blood
concentrations of homocysteine and depression in general popula-
tions and among psychiatric patients are inconsistent.
Objective: The objective was to study the association between
depression and serum concentrations of total homocysteine (tHcy).
Design: A cross-sectional study of a sample of 924 men aged 46–64
y was conducted as a part of the Kuopio Ischaemic Heart Disease
Risk Factor Study. Those who had a history of psychiatric disorder
(6.0%) were excluded. Depressive symptoms were assessed with the
18-item Human Population Laboratory Depression Scale. Those
who scored 5 at baseline or at the 4-y follow-up were considered
to have a tendency toward depression.
Results: The participants were ranked according to their blood tHcy
concentration and divided into tertiles. Those in the upper tertile for
serum tHcy had a more than twofold (odds ratio: 2.30; 95% CI: 1.35,
3.90; P  0.002) higher risk of being depressed than did those in the
lowest tertile for serum tHcy. The results remained significant after
adjustment for the month of study, history of ischemic heart disease,
smoking habits, alcohol consumption, marital status, education, and
socioeconomic status in adulthood (odds ratio: 2.23; 95% CI: 1.30,
3.83; P  0.004).
Conclusion: High serum concentrations of tHcy may be associated
with depression in middle-aged men. Am J Clin Nutr 2004;80:
1574–8.
KEY WORDS Depression, homocysteine, folate, Kuopio
Ischaemic Heart Disease Risk Factor Study
INTRODUCTION
Low blood folate and cobalamin (vitamin B-12) concentra-
tions have been found in patients with major depression in a
number of studies (1–4). Furthermore, low blood folate concen-
trations have been associated with a poor response to antidepres-
sant treatment (5, 6), and in some studies there has been an
inverse correlation between blood folate concentrations and the
severity of depression (2, 5).
A connection between B-vitamin status and depression could
be explained by direct effects of the vitamins on monoamine
metabolism in the central nervous system (CNS). However, low
B-vitamin status leads to hyperhomocysteinemia, which has
been linked to other neuropsychiatric disorders, including Alz-
heimer disease. Thus, it has been suggested that hyperhomocys-
teinemia itself could cause or aggravate depression (7, 8). In
addition to poor diet, lifestyle factors such as smoking (9) and
high alcohol consumption (10) have been found to increase total
homocysteine (tHcy) concentrations. Depression is also known
to be associated with several lifestyle factors (11, 12). Thus,
several lifestyle-connected confounders may bias the results of
studies on the association between tHcy and medical conditions.
Bell et al (13) suggested that homocysteine may play a role in
depression among the elderly. However, studies of the relation
between tHcy and depression have been contradictory. For ex-
ample, Bottiglieri et al (14) found that high concentrations of
tHcy in psychiatric inpatients were associated with more severe
depression as measured with the use of the Hamilton Depression
Rating Scale (15), and Bjelland and coworkers (16) found an
increased risk of depression in association with high plasma tHcy
concentrations in the general population. Furthermore, results of
a randomized placebo-controlled trial suggested that enhance-
ment of the effectiveness of the antidepressant fluoxetine by the
coadministration of folic acid (500 fg/d) was due to the reduction
in tHcy. Specifically, tHcy was related to Hamilton Depression
Rating Scale scores in the group treated with both folic acid and
fluoxetine, but not to those in the placebo group or the group
treated with fluoxetine alone (17). Several studies failed to sup-
port an independent role for elevated tHcy concentrations in
depression: 3 studies found no association between tHcy and
depression (6, 18, 19), and a population-based study showed the
disappearance of an association between tHcy and depression
after correction for cardiovascular disease risk factors and func-
tional disability (20). In this study, we used data collected in the
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Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD
Study) to examine the relation between tHcy concentrations and
depression among middle-aged Finnish men.
SUBJECTS AND METHODS
Subjects
The KIHD Study is an ongoing, population-based study de-
signed to investigate risk factors for cardiovascular disease and
other outcomes in middle-aged men from eastern Finland (21). A
total of 2682 participants (82.9% of those eligible), aged 42, 48,
54, or 60 y, were enrolled in the baseline study between 1984 and
1989. The study protocol was approved by the Research Ethics
Committee of the University of Kuopio and Kuopio University
Hospital, and the subjects gave written informed consent.
Out of a total of 1229 men invited for the 4-y follow-up of the
KIHD Study, 52 had died, had severe illness, or migrated from
the region, and 139 either could not be contacted or refused to
participate. Of the remaining 1038 men, data were incomplete for
110 men. Those who reported having been previously diagnosed
as having any psychiatric disorder were excluded (n  57, 6.0%
of the cohort), which left 871 men for analysis.
Measurements
The subjects came to the Research Institute of Public Health to
provide venous blood samples between 0800 and 1000. They had
been instructed to abstain from ingesting alcohol for the previous
3 d and from smoking and eating for 12 h before presenting. After
the subjects had rested in a supine position for 30 min, blood
samples were obtained by venipuncture and collected into vac-
uum tubes (Venoject; Terumo, Leuven, Belgium). No tourniquet
was used. Blood for tHcy measurements was drawn into serum
tubes. Serum was separated within 60 min and stored at 20 °C
before analysis. The CV between batches (n  30) for 2 pooled
plasma samples was 4.3% and 5.4%. Analysis of tHcy by using
HPLC was conducted in 2001 at the National Public Health
Institute, Helsinki, as described by Schwab et al (22).
The serum tHcy samples were kept in storage for 7 y at
20 °C before analysis. The distribution of values from assays of
stored samples is similar to that of values from assays of freshly
drawn blood. Alfthan et al (23) tested the stability of tHcy sam-
ples that had been kept in storage for 7 y at 20 °C and thawed
twice without significant deterioration. The mean serum tHcy
concentration had been 9.1 mol/L (range: 6.9–13.2 mol/L) at
baseline, and that 7 y later was 9.3 mol/L (range: 7.5–13.2
mol/L) (23). This suggests that the deterioration of tHcy sam-
ples was unlikely in our study.
Measurements of serum -tocopherol, lycopene, and choles-
terol concentrations were presented elsewhere (24). Serum for
-tocopherol, lycopene, and -carotene measurements was
stored at 80 °C until extracted with ethanol and hexane and
measured by using an HPLC method in which -tocopherol
acetate was an internal standard (25). Lipoproteins were sepa-
rated from fresh serum samples by combined ultracentrifugation
and precipitation (26). The serum total cholesterol (Kone Instru-
ments, Espoo, Finland) concentrations were measured enzymat-
ically with the use of an autoanalyzer (Kone Specific, Kone
Instruments).
Assessment of depressive symptoms
Depressive symptoms were assessed with the use of the self-
administered 18-item Human Population Laboratory Depression
Scale (HPL Scale), which was specifically developed for screen-
ing general population samples (27, 28) and which is highly
correlated with the 21-item Beck Depression Inventory score
(29, 30). The HPL Scale consists of items dealing with mood
disturbance, a negative self-concept, loss of energy, problems
with eating and sleeping, difficulty in concentrating, and psy-
chomotor retardation or agitation. The HPL Scale score is gen-
erated by assigning one point for each true or false answer that is
indicative of depression. After exclusion of the subjects with
previous psychiatric disorder, Cronbach’s  for the HPL Scale
was 0.69 at baseline and 0.65 on follow-up. A cutoff of 5 was
used earlier to define clinically significant depression (29), and
we therefore applied the same cutoff in this study. Those who
scored 5 either at baseline or on 4-y follow-up were considered
to have a tendency toward depression (n  109; 12.2% of par-
ticipants). Poor appetite as a covariate was derived from the HPL
Scale.
Other characteristics
Participants also completed questionnaires at baseline that
evaluated their sociodemographic background, current smoking
habits (yes or no), alcohol consumption (g/wk), marital status,
and education. Marital status was converted to the variable “liv-
ing alone” (living in marriage or in common-law marriage or
living alone). A variety of indicators of adult socioeconomic
status were available, including current income, current and pre-
vious occupations, the highest level of education, the perception
of financial security, and housing tenure. In addition, an index of
material living conditions was created by summing the number
of material possessions from a list of 12 (eg, dishwasher, car, and
telephone). The variable “adult socioeconomic status” was
formed from these indicators. The weight and height of the par-
ticipants were measured by a nurse, and the body mass index (in
kg/m2) was computed. Subjects were defined as smokers if they
had ever smoked on a regular basis and had smoked any ciga-
rettes or cigars or a pipe within the previous 30 d.
Statistical analysis
Differences in the assessed characteristics between depressed
participants and the rest of the cohort were examined by using
Student’s t test, the Mann-Whitney U test, and the chi-square test.
Participants were also ranked and divided into tertiles according
to their serum tHcy concentrations. Differences in the assessed
characteristics between subjects according to tertiles of serum
tHcy concentrations were examined by using analysis of vari-
ance, the chi-square test, and the Kruskal-Wallis test. The cutoff
of 11.9 mol/L that we used to indicate an elevated serum tHcy
concentration is the same as was used in an earlier study (14).
Correlations were examined with the use of Pearson’s correlation
test.
Odds ratios relating depression to serum concentrations of
tHcy were calculated by using a logistic regression model after
adjustment for age and the year of the examination (model 1) and
further adjustment for history of ischemic heart disease, smoking
habits, alcohol consumption, living alone, education, and adult-
hood socioeconomic status (model 2). We chose these covariates
because they are known to associate with depression or tHcy















concentrations or both (9, 10, 11, 12, 31). Model 2 was also
adjusted further for poor appetite. Serum tocopherol, lycopene,
and total cholesterol were used as additional covariates to form
model 3 from model 2. High concentrations of serum tocopherol
and lycopene and low concentrations of total cholesterol may
reflect a healthy diet. Model 3 was created to investigate the
possibility that a healthier diet among the nondepressed partici-
pants could bias the results or that the other healthy characteris-
tics of food could explain the association between depression and
tHcy concentrations.
RESULTS
The characteristics of the study subjects with and without
depression are presented in Table 1. Depressed participants were
more likely than were the other participants to have a history of
ischemic heart disease and poor appetite, and they also had higher
serum tHcy concentrations.
The characteristics of the study population according to the
tertiles of serum tHcy are summarized in Table 2. Higher con-
centrations of tHcy were associated with older age, living alone,
and a poor appetite.
The serum tHcy concentration was elevated (cutoff  11.9
mol/L) in 36.7% of the depressed participants and in 26.4% of
the nondepressed participants (P  0.024). The mean HPL Scale
scores were significantly higher among those with an elevated
serum tHcy concentration than among other study subjects
(x  SD HPL Scale score: 1.6  1.9 compared with 1.3  1.7;
P  0.005).
Depression was most common among participants whose ho-
mocysteine concentrations were in the upper tertile. Further-
more, there was a linear trend in the proportions of depressed
participants (Table 2).
In model 1, depression was more than twice as common among
men whose serum tHcy concentrations were in the highest tertile
than among men whose serum tHcy concentrations were in the
lowest tertile (OR: 2.30; 95% CI: 1.35, 3.90; P  0.002). In
multivariate analysis adjusted for ischemic heart disease history,
smoking habits, alcohol consumption, living alone, education,
and adulthood socioeconomic status (model 2), the risk was at the
TABLE 1







(n  762) P for difference
Age (y) 57.0  6.22 55.9  6.8 0.1283
Alcohol intake (g/wk) 91.7  133.4 74.6  123.5 0.3514
BMI (kg/m2) 27.5  3.5 27.6  3.7 0.7033
Graduated from high school (%) 15.6 11.8 0.2605
Living alone (%) 10.1 11.2 0.7405
Smoker (%) 34.9 30.4 0.3515
Symptomatic IHD or IHD history (%) 31.2 19.2 0.0045
Poor appetite (%) 13.3 3.6 0.0015
Serum homocysteine (mol/L) 11.9  5.0 10.8  3.1 0.0033
1 HPL Scale, Human Population Laboratory Depression Scale; IHD, ischemic heart disease.
2 x  SD (all such values).
3 Student’s t test.
4 Mann- Whitney U test.
5 Chi-square test.
TABLE 2







(n  291) P
Serum tHcy (mol/L) 2.8–9.61 9.6–11.4 11.4–51.2 —
Depressed cases [n (%)] 23 (7.9) 37 (12.7) 49 (17.1) 0.0012
Serum homocysteine (mol/L) 8.8  1.03 10.4  0.5 14.0  4.3 0.0014
Age (y) 54.9  6.6 55.9  6.8 57.6  6.5 0.0014
Alcohol intake (g/wk) 80.2  113.3 70.7  101.9 78.9  156.1 0.1982
BMI (kg/m2) 27.7  3.6 27.5  3.5 27.5  3.5 0.5844
Graduated from high school (%) 10.7 11.4 15.1 0.1045
Living alone (%) 9.0 9.4 14.4 0.0355
Smoker (%) 28.8 28.6 25.1 0.3145
Poor appetite (%) 2.0 3.1 6.5 0.0055
1 Range (all such values).
2 Kruskal-Wallis test.
3 x  SD (all such values).
4 ANOVA, P for trend.
5 Chi-square test, P for linear trend.















same level (OR: 2.23; 95% CI: 1.30, 3.83; P  0.004). The risk
of depression in participants in the middle tertile was also almost
significantly elevated in model 1 (OR: 1.65; 95% CI: 0.95, 2.86;
P  0.059) and in model 2 (OR: 1.67; 95% CI: 0.96, 2.91; P 
0.068). Further adjustment of model 2 for poor appetite slightly
weakened the association (OR: 1.97; 95% CI: 1.14, 3.41; P 
0.016). Adjustment for serum tocopherol, lycopene, and total
cholesterol did not significantly change the results of the analysis
(OR: 2.21; 95% CI: 1.29, 3.79; P  0.004).
We also repeated the analyses after the exclusion of all those
participants who had a history of any cancer or any cardiovas-
cular disease except hypertension. This left 658 participants to be
analyzed, of whom 52 had a tendency toward depression. The
results were essentially the same in model 1 (OR: 2.20; 95% CI:
1.05, 4.58; P  0.037) and in model 2 (OR: 2.24; 95% CI: 1.06,
4.74; P  0.035).
DISCUSSION
In the current study, participants whose serum tHcy concen-
trations were in the highest tertile had a risk of depression that
was more than twice that of participants whose serum tHcy con-
centrations were in the lowest tertile. These results are consistent
with those of 2 previous analyses of data from the same study.
Specifically, using the baseline data, we found a cross-sectional
association between low folate intake and depression (32). Fur-
thermore, we showed prospectively that having a low-folate diet
at baseline increased one’s risk of receiving a hospital discharge
diagnosis of depression during 11–16 y of follow-up (33). Find-
ings from all 3 of these studies support the hypothesis that folate-
homocysteine metabolism is associated with depression in
middle-aged men from eastern Finland. It is not known whether
these findings can be generalized to Finnish women, Finnish men
of different ages, or to subjects in other countries.
Morris et al (19) found that blood folate concentrations, but not
plasma tHcy concentrations, were associated with depression in
the general US population. However, the mean age of the sub-
jects in that study was only 26.2 y, whereas it was 56.1 y among
the subjects in the current study. As might be predicted from the
age difference, mean tHcy concentrations also differed mark-
edly. Whereas the mean tHcy concentration in the depressed
young Americans in that study was 8.5 mmol/L, that of the
depressed older subjects in the current study was nearly 12
mmol/L.
More than one-third of the depressed participants in the current
study had high tHcy concentrations (cutoff: 11.9 mol/L).
Bottiglieri et al (14) recorded increased plasma tHcy concentra-
tions in 52% of depressed inpatients by using the same cutoff as
we did, whereas Fava et al (6) observed increased tHcy concen-
trations in 20% of depressed outpatients (cutoff: 13.1 mol/L).
A comparison between the findings of Bottiglieri et al and those
of Fava et al might ascertain that patients with more severe
depression who require hospitalization also have higher concen-
trations of tHcy than do outpatients. However, a high concentra-
tion of tHcy was also a common finding in our general population
sample. It may be connected with a low intake of folate, because
previous studies on this sample showed that only 25% of the
subjects reached the recommended daily intake of 300 g folate
(32–35).
The mechanisms of homocysteine’s action in the CNS and its
link with depression are unclear. It has been suggested that ho-
mocysteic acid and cysteine sulfinic acid, as metabolites of ho-
mocysteine, may have an excitotoxic effect on the N-methyl-D-
aspartate receptors in the CNS. They may also inhibit the
S-adenosylmethionine–dependent methylation of biogenic
amines and phospholipids (8, 36). One way to metabolize ho-
mocysteine is to methylate it back into methionine, the immedi-
ate precursor of S-adenosylmethionine, which in turn serves as
the methyl donor in many methylation reactions in the synthesis
of the monoamines. Thus, although tHcy could theoretically
cause depression via direct neurotoxicity, an elevated plasma
tHcy concentration may merely be a marker of impaired mono-
amine metabolism, which causes depression through reduced
CNS methylation.
An elevated serum tHcy concentration, rather than being an
independent risk factor, may be an indicator of an unhealthy
lifestyle, which in turn leads to an increased risk of depression.
However, in our sample, many other well-known risk factors for
depression were not associated with an increased serum tHcy
concentration, and adjustment for those risk factors did not
change the results. Poor appetite as a symptom of depression
could lead to a decreased intake of B vitamins, which could then
lead to elevated concentrations of tHcy, but adjustment for poor
appetite did not change the results. Deterioration of the samples
during storage could also bias our results. However, Alfthan et al
(23) did not find deterioration during a similar storage period.
Several serious, long-term diseases have been linked to hy-
perhomocysteinemia, and having such a disease may be another
cause of depression. Connections of this kind that are currently
unknown may bias our findings. To avoid this as far as possible,
we also performed the analysis by excluding all those partici-
pants who had any history of cancer or chronic heart disease, and
that exclusion did not change the results.
We did not use a structured interview to identify psychiatric
disorders according to specific diagnostic criteria, as some other
investigators have done (19, 20). Thus, some of the study par-
ticipants whom we classified as depressed might not have qual-
ified for a psychiatric diagnosis such as major depressive episode
or dysthymia. However, the similarity between the prevalence of
depressive symptoms in our study (ie, 10.4% at baseline and
7.3% on 4-y follow-up, if those with a psychiatric history were
included) and the estimate by Lindeman et al (37) of the preva-
lence of major depressive episode (7.2%) among Finnish men
aged 15–75 y may suggest that subjects who scored 5 on the
HPL Scale had experienced a clinically important depressive
episode. Nevertheless, we do not claim that an HPL Scale score
5 is exactly the same as a clinical diagnosis of depression. We
included in our study sample all men who had a HPL Scale score
5 either at baseline or on follow-up, because there is some
evidence that depressive symptoms are persistent and relatively
stable over time. The subthreshold depressive symptoms also
seem to be stable (38).
Conclusion
This study indicates that homocysteine metabolism a plays
role with respect to depression, at least in middle-aged men from
eastern Finland. Together, this study and our previous studies on
this material support the link between folate-homocysteine me-
tabolism and depression. Further research is needed to determine















whether these associations are linked to age, sex, or diet or to
other, underlying biologic factors.
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